Carbetocin Nasal Spray

DRUG2 trials

Sponsors

Acadia Pharmaceuticals Inc.

Conditions

Hyperphagia related behaviour associated with Prader-Willi Syndrome (PWS)

Phase 3

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

CompletedCTIS2023-506200-24-00

Acadia Pharmaceuticals Inc.Hyperphagia related behaviour associated with Prader-Willi Syndrome (PWS)

Start: 2025-01-10End: 2025-08-19Target: 98Updated: 2025-06-30

A Long-term, Open-label Extension Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi Syndrome

RecruitingCTIS2023-506201-19-00

Acadia Pharmaceuticals Inc.Hyperphagia related behaviour associated with Prader-Willi Syndrome (PWS)

Start: 2025-04-28Target: 48Updated: 2025-09-16